Category Archives: Alzheimer’s Disease

Can Eye Exams Help Prevent Alzheimer’s Disease?

August 23, 2019

Often performed on aging patients at risk of serious eye conditions such as blindness, eye exams may soon prove to be powerful tools in the detection of brain disease. As a practical, preventative measure, eye examinations assist physicians in observing and determining the deterioration of eye health in aging patients, helping to protect against crippling impairment. It is estimated that nearly 50% of blindness cases can be avoided or prevented with routine visits to an eye care professional, according to Harvard Health Publishing Continue reading →

Preventing Dementia in Patients with Mild Cognitive Impairment

July 10, 2019

According to data from the American Academy of Neurology (AAN), an estimated 6% of people worldwide suffer from mild cognitive impairment (MCI) in their 60s, and 37% are affected by age 85. Although patients with mild cognitive impairment have an increased risk of developing dementia, the condition does not always worsen and growing research aims to determine the underlying mechanisms linking the two. The progression from MCI, a slight but noticeable change in cognitive function, to dementia is not automatic; about 15% of MCI cases develop into dementia.

Continue reading →

Could a Cognoscopy Prevent Alzheimer’s Disease Development?

April 22, 2019

Alzheimer’s disease is a complex, multi-faceted condition affecting nearly 47 million people worldwide, with 5.8 million Americans currently living with dementia in 2019. Already one of the leading causes of death in the United Kingdom, the disease is expected to rise to the forefront in the U.S. as heart disease and cancer treatments continue to improve. According to the 2019 Alzheimer’s Disease Facts and Figures report, there has been an increase of 145% in Alzheimer’s related deaths between 2000 and 2017.

An estimated 75 million Americans are predisposed to developing Alzheimer’s disease, and this number is only expected to grow. New research suggests that the development of Alzheimer’s begins 20 or more years before any noticeable symptoms arise, allowing for a substantial window of time for intervention and prevention. With advancing technology and further research, there is potential to decrease the prevalence of Alzheimer’s to a much lower level by interceding at earlier stages than thought possible before.

Continue reading →